The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs
Margaret Hellard(The Alfred Hospital), Emma S. McBryde(The University of Queensland), Rachel Sacks‐Davis(Burnet Institute), David A. Rolls(Australian Psychological Society), Philippa Pattison(The University of Sydney), Campbell Aitken(Burnet Institute), Garry Robins(The University of Melbourne), Peter Higgs(Curtin University)
Cited by 134
Related Papers
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
|The Lancet|2016|648
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
|Hepatology|2013|393
Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
|Clinical Infectious Diseases|2009|234
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2018|228